Blog

Lawmakers have recently proposed changes to the Social Security benefits program. But as we move into an election year and partisan conflict remains, it's unlikely any major legislation will pass in

Argenx (NASDAQ: ARGX) is a biotechnology stock that recently shot higher following FDA approval of its first drug. Efgartigimod is now the first drug of its kind approved to treat a debilitating

With the tech-heavy Nasdaq having outperformed the general markets over the past few years, you might not think there are any cheap tech stocks left. However, the recent tech sell-off has caused a

CrowdStrike (NASDAQ: CRWD), one of the hottest cybersecurity stocks of 2019 and 2020, cooled off significantly this year. CrowdStrike ended 2020 at $211.82 per share -- 523% above the price of its

If you're gearing up to retire in 2022, you may be growing increasingly excited about that prospect by the day. But the decisions you make early on in retirement could determine how financially

It's hard to believe, but the first COVID-19 cases were in late 2019, meaning the pandemic entered its third year a couple of months ago. With new variants cropping up, including omicron, it

On (very) rare occasions, you can have your cake and eat it too when you're investing in cannabis stocks. Trulieve Cannabis (OTC: TCNNF) has had a rough year, falling by 25% amid a backdrop of many

There's nothing more exciting for me as an investor than when I notice that one of my stocks is surging after finally getting its value recognized by the market. While there's no way to know for

Despite the S&P 500 surging 29% year to date, it's been a tough year for many investors. Lots of growth stocks, for instance, have underperformed this year -- and some have plummeted. Zoom Video

It isn't a stretch to argue that the world literally can't live without the steady innovation taking place throughout the healthcare industry. The world is aging, and more people are being diagnosed

Retirees love dividend stocks because they produce cash flow, but yield isn't the only thing you have to consider. It's also important to understand the quality, risk, and growth potential of the

As with any evolving industry, the marijuana industry also suffers from volatility. The Canadian industry, in particular, has faced several headwinds since it legalized medical and recreational

It's been a great year for Ethereum (CRYPTO: ETH) even with the recent pullback. The price of the blockchain's ETH native token has soared more than 440%. With a surge in the final days of December

Want to have a really happy new year? Invest now in stocks that are likely to really take off in 2022. Granted, that's easier said than done. There's no way to know for sure which stocks will

In 11 days, Wall Street will turn the page on what looks to be another stellar year. Through Dec. 15, the benchmark S&P 500 has gained 25%. That's well over double its average annual total return

After a record-breaking year, the stock market has had a bumpy few weeks. The S&P 500 fell nearly 5% in September, then after a rebound in October, it dropped around 4% during the last three weeks

The start of a new year brings with it some New Year's resolutions. One of your goals may be to invest in the stock market for the first time. Or perhaps you have started investing only recently and

Patience has paid off immensely over the long run for stock investors. Since 1980, the benchmark S&P 500 has averaged an annual total return, including dividends, of roughly 11%.

However, cryptocurr

Whether you're single during retirement or married, there's a good chance Social Security will end up serving as an essential income source for you. But if you're married, you may have more options

The tax-exempt Roth IRA is one of the most effective retirement planning vehicles, and the sooner you take full advantage of its benefits, the better off you'll be in the long run. The only real

There were few standouts this weekend in what was generally a sleepy few days for cryptocurrency trading. One notable exception was Arweave (CRYPTO: AR), which as of noon on Sunday was up by more

In this segment of Backstage Pass, recorded on Nov. 17, Fool contributors Rachel Warren, Travis Hoium, and Connor Allen discuss their approaches to building cash positions while consistently buying

There's unrest in the live TV streaming space, and it represents both an opportunity and a challenge for fuboTV (NYSE: FUBO). Subscribers to Alphabet's (NASDAQ: GOOG) (NASDAQ: GOOGL) YouTube TV no

In this segment of "Industry Focus" on Motley Fool Live, recorded on Dec. 7, Fool senior analyst Asit Sharma discusses the next-generation process of buying an engagement ring from Brilliant Earth

Some biotech stocks follow the old maxim that "what goes up will come down." Others, though, adhere to a more upbeat principle: winners win.

We asked three Motley Fool contributors to pick biotech